A Regional Economic Development Agency, a Medical Biotechnology Spinout Ltd, UK

A Scottish medical biotechnology spinout required strategic advisory to complete techno-economic due diligence, refine its commercial strategy, and secure Series A funding for its novel diagnostic platform. The leadership sought an authoritative, independent strategic evaluation to optimize grant allocation mechanisms, streamline technology transfer workflows, and align regional innovation policies with global best practices.

Oxford Oracle conducted rigorous technical validation, market sizing, and investor pitch preparation, working closely with the executive management team and regional economic development agency. Oxford Oracle deployed a multidisciplinary advisory team to execute comprehensive technical due diligence, design bespoke commercialisation roadmaps, and establish standardized stage-gate evaluation metrics.

The spinout successfully closed a £3.8 million Series A investment round led by Scottish syndicate investors, accelerating clinical trial execution and expanding its diagnostic product pipeline. Furthermore, the engagement established a permanent, scalable operational blueprint, driving long-term strategic alignment, continuous revenue growth, and enhanced institutional reputation across global innovation networks.